No Detail Found!

Long-term valuation of oral mavacoxib in osteoarthrosic dogs using force platform analysis.

Author(s)
J. M. Vilar Department of Animal Pathology, Faculty of Veterinary Medicine, University of Las Palmas de Gran Canaria, Trasmontaña S/N, Arucas. 35413. Las Palmas, Spain
M. Morales Department of Animal Pathology, Faculty of Veterinary Medicine, University of Las Palmas de Gran Canaria, Trasmontaña S/N, Arucas. 35413. Las Palmas, Spain
A. Santana Department of Animal Pathology, Faculty of Veterinary Medicine, University of Las Palmas de Gran Canaria, Trasmontaña S/N, Arucas. 35413. Las Palmas, Spain
M. Batista Department of Animal Pathology, Faculty of Veterinary Medicine, University of Las Palmas de Gran Canaria, Trasmontaña S/N, Arucas. 35413. Las Palmas, Spain
F. Miró Department of Compared Anatomy and Pathology, Veterinary Faculty, University of Córdoba, Campus de Rabanales, Ctra. Madrid-Cádiz Km 396 A, Córdoba, Spain
G. Spinella Department of Health Sciences, University Magna Graecia of Catanzaro, Germaneto (CZ), Italy
Abstract
The aim of this study was to assess the efficacy of mavacoxib, a cox-2 inhibitor, to improve the peak vertical force (PVF) and vertical impulse (VI) of lame clientowned dogs with severe coxofemoral osteoarthrosis (OA) by using a force platform. A group of ten canarian presa dogs with lameness and pain for a severe osteoarthrosis due to hip dysplasia were used for this study. Five additional sound dogs of the same breed were used as control groups. A single force platform used to register vertical forces was mounted in a 7 m runway. Mean (± SD) values for speed of dogs were 1.6±0.5 m/s. Data corresponding with 5 valid trials were recorded at walk at day 0, 7, 60 and 180 after starting treatment procedure. The dosing regimen consisted of a loading oral dose of 2 mg⁄ kg to be repeated after 14 days, thereafter the dosing interval was 1 month. OA dogs showed a significant improvement of PVF after two months of about 7% bm in the force exerted by diseased limbs and a significant VI improvement after two months of about 1.6% bm in the VI exerted by diseased limbs. This study clearly showed that dogs treated with mavacoxib increased PVF over time, as soon as seven days after medical therapy, demonstrating a high potential for clinical use in the treatment of lameness associated with OA of hip joint.
Publication Details
Page(s) 229-233
DOI DOI not available
Published Journal: Pakistan Veterinary Journal, Volume: 33, Issue: 2, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

125

Views